Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$25.1 - $31.61 $13,428 - $16,911
535 Added 6.44%
8,848 $233,000
Q1 2024

May 10, 2024

SELL
$30.27 - $43.79 $53,789 - $77,814
-1,777 Reduced 17.61%
8,313 $268,000
Q4 2023

Feb 14, 2024

BUY
$31.31 - $44.19 $3,005 - $4,242
96 Added 0.96%
10,090 $425,000
Q3 2023

Nov 13, 2023

BUY
$18.55 - $39.96 $185,388 - $399,360
9,994 New
9,994 $383,000

Others Institutions Holding IMVT

About Immunovant, Inc.


  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.